Restricted accessResearch articleFirst published online 2012-10
Myeloperoxidase-Derived Chlorinating Species Induce Protein Carbamylation Through Decomposition of Thiocyanate and Urea: Novel Pathways Generating Dysfunctional High-Density Lipoprotein
Aims: Protein carbamylation through cyanate is considered as playing a causal role in promoting cardiovascular disease. We recently observed that the phagocyte protein myeloperoxidase (MPO) specifically induces high-density lipoprotein (HDL) carbamylation, rather than chlorination, in human atherosclerotic lesions, raising the possibility that MPO-derived chlorinating species are involved in cyanate formation. Results: Here, we show that MPO-derived chlorinating species rapidly decompose the plasma components thiocyanate (SCN) and urea, thereby promoting (lipo)protein carbamylation. Strikingly, the presence of physiologic concentrations of SCN completely prevented MPO-induced 3-chlorotyrosine formation in HDL. SCN scavenged a 2.5-fold molar excess of hypochlorous acid, promoting HDL carbamylation, but not chlorination. Cyanate significantly impaired (i) HDL's ability to activate lecithin-cholesterol acyltransferase; (ii) the activity of paraoxonase, a major HDL-associated anti-inflammatory enzyme; and (iii) the antioxidative activity of HDL. Innovation: Here, we report that MPO-derived chlorinating species preferentially induce protein carbamylation—rather than chlorination—in the presence of physiologically relevant SCN concentrations. The carbamylation of HDL results in the loss of its anti-inflammatory and antioxidative activities. Conclusion: MPO-mediated decomposition of SCN and/or urea might be a relevant mechanism for generating dysfunctional HDL in human disease. Antioxid. Redox Signal. 00, 000–000.
ArlandsonM, DeckerT, RoongtaVA, BonillaL, MayoKH, MacPhersonJC, HazenSL, SlungaardA. Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. J Biol Chem, 276:215–224. 2001.
3.
AshbyMT, CarlsonAC, ScottMJ. Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids. J Am Chem Soc, 126:15976–15977. 2004.
4.
AviramM, HardakE, VayaJ, MahmoodS, MiloS, HoffmanA, BillickeS, DraganovD, RosenblatM. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation, 101:2510–2517. 2000.
5.
AviramM, RosenblatM, BisgaierCL, NewtonRS, Primo-ParmoSL, La DuBN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest, 101:1581–1590. 1998.
6.
BergtC, PennathurS, FuX, ByunJ, O'BrienK, McDonaldTO, SinghP, AnantharamaiahGM, ChaitA, BrunzellJ, GearyRL, OramJF, HeineckeJW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A, 101:13032–13037. 2004.
7.
DammM, HolzerM, RadspielerG, MarscheG, KappeCO. Microwave-assisted high-throughput acid hydrolysis in silicon carbide microtiter platforms—a rapid and low volume sample preparation technique for total amino acid analysis in proteins and peptides. J Chromatogr A, 1217:7826–7832. 2010.
8.
DirnhuberP, SchutzF. The isomeric transformation of urea into ammonium cyanate in aqueous solutions. Biochem J, 42:628–632. 1948.
9.
DomiganNM, CharltonTS, DuncanMW, WinterbournCC, KettleAJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem, 270:16542–16548. 1995.
10.
El-GamalD, HolzerM, GausterM, SchichoR, BinderV, KonyaV, WadsackC, SchuligoiR, HeinemannA, MarscheG. Cyanate is a novel inducer of endothelial icam-1 expression. Antioxid Redox Signal, 16:129–137. 2012.
11.
GanKN, SmolenA, EckersonHW, La DuBN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos, 19:100–106. 1991.
12.
GarnerB, WaldeckAR, WittingPK, RyeKA, StockerR. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem, 273:6088–6095. 1998.
13.
GoyalJ, WangK, LiuM, SubbaiahPV. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation. J Biol Chem, 272:16231–16239. 1997.
14.
HolzerM, Birner-GruenbergerR, StojakovicT, El-GamalD, BinderV, WadsackC, HeinemannA, MarscheG. Uremia Alters HDL Composition and Function. J Am Soc Nephrol, 22:1631–1641. 2011.
Husgafvel-PursiainenK, SorsaM, EngstromK, EinistoP. Passive smoking at work: biochemical and biological measures of exposure to environmental tobacco smoke. Int Arch Occup Environ Health, 59:337–345. 1987.
17.
Kalantar-ZadehK, BrennanML, HazenSL. Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis, 48:59–68. 2006.
18.
KalmarJ, WoldegiorgisKL, BiriB, AshbyMT. Mechanism of decomposition of the human defense factor hypothiocyanite near physiological pH. J Am Chem Soc, 133:19911–19921. 2011.
19.
KontushA, ChapmanMJ. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol, 21:312–318. 2010.
20.
KrausLM, ElbergerAJ, HandorfCR, PabstMJ, KrausAPJr.Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis. J Lab Clin Med, 123:882–891. 1994.
21.
MacknessMI, ArrolS, DurringtonPN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett, 286:152–154. 1991.
22.
MarscheG, FurtmullerPG, ObingerC, SattlerW, MalleE. Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro. Cardiovasc Res, 79:187–194. 2008.
23.
MarscheG, HammerA, OskolkovaO, KozarskyKF, SattlerW, MalleE. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem, 277:32172–32179. 2002.
24.
MorganPE, PattisonDI, TalibJ, SummersFA, HarmerJA, CelermajerDS, HawkinsCL, DaviesMJ. High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radic Biol Med, 51:1815–1822. 2011.
25.
OleaF, ParrasP. Determination of serum levels of dietary thiocyanate. J Anal Toxicol, 16:258–260. 1992.
26.
PattisonDI, DaviesMJ. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem, 13:3271–3290. 2006.
27.
PattisonDI, HawkinsCL, DaviesMJ. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol, 22:807–817. 2009.
28.
RobertsJM, VeresPR, CochranAK, WarnekeC, BurlingIR, YokelsonRJ, LernerB, GilmanJB, KusterWC, FallR, de GouwJ. Isocyanic acid in the atmosphere and its possible link to smoke-related health effects. Proc Natl Acad Sci U S A, 108:8966–8971. 2011.
RutiliG, ArforsKE. Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue. Acta Physiol Scand, 99:1–8. 1977.
31.
SheZG, ChenHZ, YanY, LiH, LiuDP. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. Antioxid Redox Signal, 16:597–632. 2012.
32.
SmithEB, StaplesEM. Distribution of plasma proteins across the human aortic wall—barrier functions of endothelium and internal elastic lamina. Atherosclerosis, 37:579–590. 1980.
33.
StarkGR. Reactions of cyanate with functional groups of proteins. II. Formation, decomposition, and properties of N-carbamylimidazole. Biochemistry, 4:588–595. 1965.
34.
StarkGR. On the reversible reaction of cyanate with sulfhydryl groups and the determination of Nh2-terminal cysteine and cystine in proteins. J Biol Chem, 239:1411–1414. 1964.
35.
van DalenCJ, WhitehouseMW, WinterbournCC, KettleAJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J, 327,Pt 2:487–492. 1997.
XuluBA, AshbyMT. Small molecular, macromolecular, and cellular chloramines react with thiocyanate to give the human defense factor hypothiocyanite. Biochemistry, 49:2068–2074. 2010.
38.
Zerrad-SaadiA, TherondP, ChantepieS, CouturierM, RyeKA, ChapmanMJ, KontushA. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Arterioscler Thromb Vasc Biol, 29:2169–2175. 2009.
39.
ZhengL, NukunaB, BrennanML, SunM, GoormasticM, SettleM, SchmittD, FuX, ThomsonL, FoxPL, IschiropoulosH, SmithJD, KinterM, HazenSL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest, 114:529–541. 2004.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
